Examkin

Question

Difficulty: HardHemodynamic and Coagulation Processes

A 65-year-old man is evaluated in the hospital on postoperative day 7 following a right total knee arthroplasty. He has been receiving prophylactic subcutaneous enoxaparin since surgery. Today, a routine complete blood count shows a platelet count of 95,000/μL, representing a significant drop from his preoperative baseline of 280,000/μL. The patient also complains of new-onset right calf pain and swelling. Physical examination reveals unilateral right lower extremity edema, erythema, and tenderness to palpation.

Arrange the following urgent diagnostic and therapeutic interventions in the most appropriate chronological sequence for managing this patient's condition.

  1. 1Discontinue the prophylactic subcutaneous enoxaparin.
  2. 2Draw a peripheral blood sample for platelet factor 4-heparin (PF4-heparin) antibody testing.
  3. 3Initiate continuous intravenous infusion of a direct thrombin inhibitor (e.g., argatroban).
  4. 4Perform bilateral lower extremity venous duplex ultrasonography.
  5. 5Initiate oral warfarin therapy only after the platelet count recovers to >150,000/μL.

Answer

The correct chronological sequence of interventions is: 1) Discontinue enoxaparin, 2) Draw blood for PF4-heparin antibodies, 3) Initiate a direct thrombin inhibitor (argatroban), 4) Perform venous duplex ultrasonography, and 5) Initiate warfarin only after platelet recovery.
The correct chronological sequence prioritizes halting the pathophysiologic trigger (stopping heparin) and immediately preventing catastrophic clot propagation (starting a direct thrombin inhibitor). Drawing diagnostic labs must precede the new drug to avoid confounding, while imaging is safely done once systemic anticoagulation is running. Finally, warfarin is strictly delayed until the acute consumptive phase resolves (platelets >150,000/μL) to prevent Protein C-depletion-induced venous limb gangrene.

Step-by-Step Solution

1
Calculate the 4T's score to determine the clinical probability of heparin-induced thrombocytopenia.
High clinical probability is established.
The patient has a >50% drop in platelets (2 points), appropriate timing of 7 days (2 points), and new suspected thrombosis (2 points), necessitating immediate action.
2
Discontinue all heparin products and draw diagnostic baseline labs.
Immune-mediated platelet activation is halted and pristine lab samples are secured.
Continuing heparin worsens the prothrombotic state. Labs must be drawn before confounding treatments are administered.
3
Initiate an alternative, non-heparin systemic anticoagulant (e.g., argatroban).
The patient is protected from further catastrophic clot propagation.
HIT is extremely prothrombotic. Systemic anticoagulation is required immediately, prior to radiographic confirmation of the local clot.
4
Obtain objective imaging (venous duplex ultrasonography) of the lower extremities.
The exact location and extent of the deep vein thrombosis are mapped.
Imaging guides localized management and establishes a baseline for future comparison once the patient is systemically safe.
5
Delay warfarin initiation until the platelet count normalizes (>150,000/μL).
Safe transition to long-term oral anticoagulation is achieved.
Early warfarin use causes severe Protein C depletion, which can trigger paradoxical venous limb gangrene in HIT patients.

Key Concept

The management of suspected Heparin-Induced Thrombocytopenia (HIT) with thrombosis requires immediate cessation of all heparin products, establishing diagnostic baseline labs, initiating an alternative non-heparin anticoagulant empirically, confirming the thrombosis via imaging, and strictly delaying warfarin initiation until platelet recovery to prevent venous gangrene.
Estimated Time:1m 30s
Rate this question

Topics

Hemodynamic and Coagulation Processes

More questions from this topic